We are live on ! Find out more
AMTX icon

Aemetis

89 hedge funds and large institutions have $109M invested in Aemetis in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

110% more call options, than puts

Call options by funds: $3.21M | Put options by funds: $1.53M

55% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 11

55% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 22

25% more capital invested

Capital invested by funds: $87.9M → $109M (+$21.6M)

7% more funds holding

Funds holding: 8389 (+6)

0.09% less ownership

Funds ownership: 51.82%51.73% (-0.09%)

Holders
89
Holders Change
+6
Holders Change %
+7.23%
% of All Funds
1.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
34
Reduced
22
Closed
11
Calls
$3.21M
Puts
$1.53M
Net Calls
+$1.68M
Net Calls Change
+$702K
Name Holding Trade Value Shares
Change
Change in
Stake
State of Wisconsin Investment Board
26
State of Wisconsin Investment Board
Wisconsin
$517K +$643K +84,539 New
Charles Schwab
27
Charles Schwab
California
$483K +$7.7K +1,011 +1%
Creative Planning
28
Creative Planning
Kansas
$476K +$44.6K +5,855 +8%
TI
29
Trexquant Investment
Connecticut
$411K +$97.4K +12,801 +24%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$408K +$428K +56,166 +538%
DC
31
Davenport & Co
Virginia
$397K -$313K -41,100 -39%
ECM
32
ExodusPoint Capital Management
New York
$341K +$177K +23,190 +71%
DKCM
33
Davidson Kempner Capital Management
New York
$338K +$421K +55,364 New
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$296K +$27.6K +3,628 +8%
Group One Trading
35
Group One Trading
Illinois
$266K -$93K -12,216 -22%
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$234K +$66.2K +8,700 +29%
SSA
37
Schonfeld Strategic Advisors
New York
$226K +$280K +36,800 New
DTL
38
Dynamic Technology Lab
Singapore
$222K +$99.8K +13,113 +57%
OQS
39
Occudo Quantitative Strategies
Florida
$200K +$132K +17,313 +113%
PI
40
PEAK6 Investments
Illinois
$186K +$231K +30,353 New
CSS
41
Cubist Systematic Strategies
Connecticut
$176K +$219K +28,764 New
Goldman Sachs
42
Goldman Sachs
New York
$170K +$2.36K +310 +1%
RJFSA
43
Raymond James Financial Services Advisors
Florida
$168K +$210K +27,528 New
VF
44
Virtu Financial
New York
$166K +$206K +27,083 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
45
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$160K -$11.1K -1,455 -5%
YCM
46
Yaupon Capital Management
New York
$158K +$197K +25,862 New
BOTOTLSJU
47
Board of Trustees of The Leland Stanford Junior University
California
$154K
Jane Street
48
Jane Street
New York
$126K +$71K +9,328 +83%
JP Morgan Chase
49
JP Morgan Chase
New York
$121K +$3.32K +436 +2%
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$114K +$69.2K +9,088 +95%

AMTX Hedge Fund Activity: Q3 2022 in Review

89 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Aemetis (AMTX) for Q3 2022, worth a combined $109M — up 25% from $87.9M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new AMTX positions and 11 closed out — a net gain of 6 holders — while 34 added to existing stakes and 22 trimmed.

The largest buyer was Millennium Management, adding an estimated $5.01M. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $2.87M.

  • 89 institutional investors held Aemetis (AMTX) as of Q3 2022, up from 83 in Q2 2022.
  • Funds reported $109M of Aemetis stock for Q3 2022, up 25% quarter-over-quarter.
  • 17 funds opened new Aemetis positions in Q3 2022 and 11 closed out, a net change of +6 holders.
  • The largest Aemetis buyer in Q3 2022 was Millennium Management, an estimated $5.01M added.
  • The largest Aemetis seller in Q3 2022 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $2.87M sold.

Based on aggregated 13F filings for Q3 2022.